Vimarsana
Biggest News Aggregation in the World

Page 2 - Gen Li News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gen Li. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gen Li Today - Breaking & Trending Today

China's sacked foreign minister Qin Gang resigns from Parliament after long absence from public view - Vimarsana News

China's sacked foreign minister Qin Gang resigns from Parliament after long absence from public view

The Standing Committee of the National People's Congress (NPC), which concluded its session here on Tuesday, said in a statement that the Tianjin Municipal People's Congress accepted Qin's resignation as a delegate to the upcoming annual parliamentary session, state-run Xinhua news agency reported.

china: China's sacked foreign minister Qin Gang resigns from Parliament after long absence from public view - Vimarsana News

china: China's sacked foreign minister Qin Gang resigns from Parliament after long absence from public view

The Standing Committee of the National People's Congress (NPC), which concluded its session here on Tuesday, said in a statement that the Tianjin Municipal People's Congress accepted Qin's resignation as a delegate to the upcoming annual parliamentary session, state-run Xinhua news agency reported.

Phesi celebrates 100 million global patient data milestone - Vimarsana News

Phesi celebrates 100 million global patient data milestone

Phesi’s artificial intelligence (AI) driven platform, Trial Accelerator, has reached a milestone and now contains global data from more than 100 million patients.

Phesi celebrates 100 million global patient data milestone - Vimarsana News

Phesi celebrates 100 million global patient data milestone

Phesi’s artificial intelligence (AI) driven platform, Trial Accelerator, has reached a milestone and now contains global data from more than 100 million patients.

Phesi releases 2023 analysis of clinical development; breast cancer remains most studied disease area for third year - Vimarsana News

Phesi releases 2023 analysis of clinical development; breast cancer remains most studied disease area for third year

Phesi releases 2023 analysis of clinical development; breast cancer remains most studied disease area for third year